baber/WOPTO huggingface dataset:
Patent CN-100411157-C (CN)
Inventor: FULIANG YANG
IPC: B22F9/08
Filed: 2006-06-30
Granted: 2008-08-13
Abstract: 本发明公开了一种高硅铝合金电子封装材料的制备工艺，A)粉末制取：将工业纯铝及高纯硅按质量比6～8.8∶4～1.2制备成Al-Si合金粉末；B)粉末的球磨处理工艺：将Al-Si合金粉末进行球磨，球料质量比为5～15∶1，球磨时间为8～32小时；C)热挤压工艺：将氧化后的合金粉末装入纯铝包套内，在300～500吨液压机上采用正向挤压方式进行挤压，挤压前对Al-Si合金粉末采用400～520℃保温0.5～2小时，挤压比为10～21，挤压前各种挤压模具首先置入加热炉中，在200～400℃充分预热保温，挤压完后即为成品。本发明是一种能显著提高材料的热导率、气密性和抗拉强度，保持材料较低的热膨胀系数，大幅度改善材料加工成形性能的高硅铝合金电子封装材料的制备工艺。
Patent CN-100424004-C (CN)
Inventor: CONGRUO WANG
IPC: C01B11/02
Filed: 2006-01-12
Granted: 2008-10-08
Abstract: 一种二氧化氯发生器，是一种用盐酸、氯酸钠作为反应原料来生产二氧化氯的设备，主要解决提高物料转化率的问题，其技术方案是，一加温箱内置有多级反应器、测温管和加温棒，加温箱内有加热介质水；多级反应器底部设有等高的空气进气管和反应物料液体出口，空气进气管连通加温箱外的进气总管，反应物料液体出口与多级反应器上部的反应物料气相出口及反应物料气相管路相通，并共同连通加温箱外的反应物料液体和气相出口；本发明用水浴加热方式及多级反应器，采用水封原理来进行曝气，物料转化率高，结构简单，便于操作，运行成本低，安全性好的设备。可用于饮用水消毒，医院污水处理，工业循环水杀菌灭藻等。
Patent CN-100515242-C (CN)
Inventor: BAOXING WANG
IPC: A24B15/10
Filed: 2006-08-31
Granted: 2009-07-22
Abstract: 本发明涉及一种降低卷烟烟气一氧化碳量的复合添加剂及其应用，所述复合添加剂主要由：烟草提取物，碱金属盐，过渡金属氢氧化物或金属氢氧化物组成。该复合添加剂适用于各种类型的烟草及其烟草制品，包括烤烟、白肋烟、晒烟和香料烟，以及膨胀烟丝、膨胀梗丝、造纸法再造烟草等烟草制品，也可以添加到卷烟纸中。本发明复合添加剂应用于卷烟后，可以选择性降低卷烟主流烟气中的一氧化碳量1.5-3.0mg/支，降低幅度达15-25%，同时能降低卷烟的焦油量。该添加剂能保持卷烟原有风格不变，并对吸味品质有一定的改善和提高。既能满足卷烟消费者的需求，又能减轻吸烟对人体的危害。
Patent CN-100458944-C (CN)
Title: 硬盘及其压块定位结构
Inventor: HUA WANG
IPC: G11B17/028
Filed: 2006-11-03
Granted: 2009-02-04
Abstract: 本发明公开了一种硬盘压块定位结构，它包括圆柱形马达、压块、紧固件及套设在该马达上的盘片，该马达的中央位置设有定位凸台，该定位凸台的中央位置设有螺纹孔，该压块压在盘片上，其中央位置具有贯穿的阶梯孔，该紧固件具有杆部，该杆部的上端设有直径较大的头部，其下端设有螺纹，该紧固件还设有环绕杆部的定位环，该紧固件的头部支撑在该阶梯孔的台阶面上，该紧固件的定位环卡在定位凸台的外壁和阶梯孔的孔壁之间，该紧固件的螺纹与该定位凸台的螺纹孔螺纹配合。通过定位环的内、外圈分别与马达的定位凸台和压块的限位孔配合，实现了双重定位，增强了压块和马达间的定位效果，进而能有效减少马达转动时压块产生的振动。
Patent CN-100589507-C (CN)
Inventor: FENG WANG
IPC: H04M3/42
Filed: 2006-10-30
Granted: 2010-02-10
Abstract: 本发明涉及一种拨号提示系统及方法，包括监测单元与拨号提示信息处理单元：监测单元，用于监测是否需要向用户发送拨号提示信息，并在监测确定需要时触发拨号提示信息处理单元；拨号提示信息处理单元按照预定的策略为所述用户确定对应的拨号提示信息，并发送给所述用户。将本发明应用于通信系统中后，若用户发送呼叫请求(如摘机)，则通信系统会产生语音信息、文本信息、图片信息和视频图像信息中的至少一项作为允许用户呼叫的指示信息，也就是说，可以使用语音信息、文本信息、图片信息和视频图像信息中的至少一项形成多种信息替代现有的单一的拨号提示音频信号。
Patent CN-100565001-C (CN)
Inventor: SHINICHI USHIJIMA
IPC: F21Y101/00
Filed: 2006-11-27
Granted: 2009-12-02
Abstract: 本发明提供一种光源装置(10)，其具备发光管(1)和反射镜(2)，其特征在于，玻璃罩(4)设有空隙(S)地以两端外插固定在反射镜(2)的后方。根据如此的构成，即使万一发光管破裂，裂纹扩展到反射镜，玻璃罩也能够防止反射镜的碎片飞散。从而，在带有反射镜的高压放电灯中，即使在高压放电灯不慎破裂时，也能防止反射镜的部件向周围飞散。
Patent CN-100590865-C (CN)
Title: 封装元件
Inventor: WUDE YANG
IPC: H01L25/00
Filed: 2006-12-21
Granted: 2010-02-17
Abstract: 本发明涉及一种封装元件，其包含有一第一基板，多个第一芯片位于该第一基板上，一第二基板位于该第一基板上，一第二芯片位于该第二基板上，一黏着层位于该第二芯片上，以及一散热器位于该第一基板、所述第一芯片、该第二基板、与该黏着层上，其中散热器具有多个开口，可以导入冷空气使其与封装元件内的热空气产生对流，以降低封装元件内的温度。
Patent CN-100436530-C (CN)
Title: 聚乙烯-醋酸乙烯酯基热可塑性木塑复合材料的制备方法
Inventor: RONGRONG QI
IPC: C08K5/10
Filed: 2007-03-15
Granted: 2008-11-26
Abstract: 本发明涉及一种聚乙烯—醋酸乙烯酯基热可塑性木塑复合材料的制备方法，采用乙烯—醋酸乙烯酯共聚物和木粉为主要原料，配以反应相容剂、抗氧剂、高分子增韧改性剂、填料、分散剂和增塑剂进行反应复合，采用连续挤出加工工艺，制备出具有柔软、防滑、防潮、隔热和可回收再利用等优点的聚乙烯—醋酸乙烯酯基热可塑性木塑复合材料，该材料具有优良的物理机械性能和可加工性能，可以做为软质塑料地板、隔热层、防滑垫等使用。
Patent CN-100538354-C (CN)
Title: 一种检测污水中雌激素活性贡献物的方法
Inventor: GANG YU
IPC: G01N30/02
Filed: 2007-01-12
Granted: 2009-09-09
Abstract: 一种检测污水中雌激素活性贡献物的方法，属于污水中有机污染物的检测技术领域。本方法将采集好的污水水样用固相萃取柱萃取富集其中的雌激素活性物质后，分别用甲醇、二氯甲烷和正己烷洗脱和硅胶色谱柱分级为极性、中极性和弱极性三种组份，不同极性的分级组份用重组基因酵母生物测试方法测定其雌激素活性，取雌激素活性最大的组份用气相色谱-质谱联机分析其中的雌激素活性物质种类和浓度。该方法可以快速、有效地检测出污水中主要的雌激素活性贡献物，为污水处理工艺的改进提供基础支持。
Patent CN-100582237-C (CN)
Title: 一种将七叶苷用于高产β-葡萄糖苷酶产生菌的平板筛选的方法
Inventor: XIN SONG
IPC: C12N1/14
Filed: 2007-11-29
Granted: 2010-01-20
Abstract: 本发明公开了一种将七叶苷用于高产β-葡萄糖苷酶产生菌的平板筛选的方法。包括(1)土样采集(2)富集培养(3)七叶苷平板制备(4)七叶苷平板初筛(5)分离纯种(6)摇瓶复筛等步骤。本发明方法能够从富含纤维素资源的样品中快速筛选出具有β-葡萄糖苷酶的活力的菌株，与已经发表的文献中所报导的以纤维二糖平板进行筛选的方法相比，具有明显的价格优势，在同样筛选获得100个菌株的情况下，本发明所述七叶苷法的花费只是纤维二糖平板法的十分之一，并且还具操作简单、结果可信等诸多优点。
Patent CN-100537811-C (CN)
Title: 顶底复吹转炉冶炼不锈钢的方法
Inventor: CHENGZHI LIU
IPC: C22C33/04
Filed: 2007-10-17
Granted: 2009-09-09
Abstract: 一种顶底复吹转炉冶炼不锈钢的方法，它包括下述依次的步骤：I把铁水兑入顶底复吹转炉并加入焦炭，吹氧气氩气进行冶炼；II钢液温度大于1600℃时，加入锰铁、铬铁合金氧气和氩气进行冶炼，加入渣料调渣；III钢液温度大于1630℃时，再次加入锰铁、铬铁合金，吹氧气吹吹氩气进行冶炼，加入渣料调渣；IV钢液实际测的温度大于计算温度时，加入其余合金锰铁、铬铁、镍，吹氧气吹氩气进行冶炼，加入石灰及少量萤石调渣；V逐渐降低吹氧量逐渐提高吹氩气量；VI停止炉底吹氧气，只吹氩气搅拌1.5分钟-2.5分钟；VII加入硅铁加入渣料；VIII还原底吹氩气搅拌时间≥5分钟；IX取样分析成分出钢。本顶底复吹转炉冶炼不锈钢的方法成本低。
Patent CN-100564138-C (CN)
Inventor: HIROYUKI ABE
IPC: B62D17/00
Filed: 2007-08-23
Granted: 2009-12-02
Abstract: 一种在进行轴调整时能使调整用螺栓不倾斜地沿调整用长孔的长度方向平滑地位移、且不会导致强度降低等的车轮定位调整结构等的轴调整结构。包括：调整用长孔(34、35)、板导向件(36、37)、调整用螺栓(38)、螺母(39)及偏心板(40、41)，偏心板(40、41)均与调整用螺栓(38)分开形成，在偏离板中心的位置形成有偏心孔(40a、41a)，供调整用螺栓(38)的轴部(38a)穿过，且在转动调整用螺栓(38)时，使卡合部(直线部40a-3、40a-4、41a-3、41a-4)与形成于轴部(8a)外周的卡合部(平坦面部8a-3、8a-4)卡合，使得偏心板(40、41)与调整用螺栓(38)一起旋转。
Patent MX-3232-E (MX)
Title: Mejoras en el procedimiento para la preparacion de organo siloxanos y halogenuros de alquilo
Inventor: WASS JOHANN
IPC: C07F7/08
Filed: 1976-05-14
Abstract: La presente invención se refiere a mejoras en el procedimiento para la preparación de organosiloxanos y halogenuros de alquilo, introduciendo un órganohalosilano y alcanol que tenga de 1 a 2 átomos de carbono en un reactor que contenga cuando menos una capa de material de empaque el cual se mantiene a una temperatura de 60 grados centígrados a 150 grados centígrados para formar una fase acuosa que contenga organosiloxanos, y después de esto, separa los organosiloxanos de la fase acuosa, caracterizadas porque comprende las siguientes etapas: recircular el reactor de 1 a 6 litros de la fase acuosa por cada mol de órganohalosilano introducido en el reactor y, hacer reaccionar los órganosiloxanos separados de la fase acuosa con 2 a 10 por ciento por peso basado en el peso de los organosiloxanos con el mismo órganohalosilano usado en la reacción inicial.
Patent PT-1108736-E (PT)
Inventor: HAAS PETER
IPC: B32B5/18
Filed: 2000-12-05
Abstract: A polyether-polyurethane foam comprises the reaction product of polyisocyanate or polyisocyanate prepolymer(s) with polyether polyol(s), aliphatic chain extender(s) (optional), aromatic polyol component(s), and blowing agent comprising water. The aromatic polyol component is at least bifunctional. A polyether-polyurethane foam comprises the reaction product of: (A) polyisocyanate or polyisocyanate prepolymer(s); with (B) polyether polyol(s) having a functionality of 2-6 and a number average molecular weight of 1000-10000 g/mol; (C) aliphatic chain extender(s) of molecular weight 62-800 (optional); (D) an at least bifunctional aromatic polyol component(s); and (E) a water blowing agent; Independent claims are also included for: (1) a process for producing the polyether-polyurethane foam; and (2) a process for producing a composite material comprising laminating polyether-polyurethane foam layer with a textile or top layer.
Patent PT-1261453-E (PT)
Inventor: LEWELLEN KEVIN
IPC: B24B31/14
Filed: 2000-03-06
Abstract: A method for polishing articles comprising soft acrylic materials is disclosed. The method includes a polishing step and a cleaning step. In the polishing step, a receptacle is charged with polishing beads of various sizes, alumina, a swelling agent and the articles to be polished, and agitated for a period of time and at a speed sufficient to remove surface irregularities. Following the polishing step, the polished articles are cleaned by agitating them with a cleaning slurry comprising cleaning beads of various sizes, alumina, a solvent and a surfactant for a period of time and at a speed sufficient to clean the surface of the polished articles. Agitation is preferably accomplished by a tumbling machine.
Patent PT-1082106-E (PT)
Title: Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl
Inventor: PATHER SATHASIVAN INDIRAN
IPC: A61K9/20
Filed: 2000-03-22
Abstract: A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed.
Patent PT-1178824-E (PT)
Title: Staphylococcus aureus antigen-containing whole cell vaccine
Inventor: FATTOM ALI I
IPC: A61K39/00
Filed: 2000-05-10
Abstract: A negatively-charged S. aureus antigen contains beta-hexosamine as a major carbohydrate component. S. aureus strains that carry the antigen account for nearly all of the clinically significant strains of S. aureus that are not Type 5 or Type 8 strains. The antigen can be used in combination with S. aureus Type 5 polysaccharide antigen and S. aureus Type 8 polysaccharide antigen to provide nearly 100% coverage of S. aureus infection. The antigen and antibodies to the antigen are useful in kits and assays for diagnosing S. aureus infection. A whole cell vaccine of cells that contain the antigen is particularly useful in the treatment of mastitis.
Patent PT-1232162-E (PT)
Title: Method for preparing silazane and/or polysilazane compounds
Inventor: ABEL ALBERT E
IPC: C07F7/10
Filed: 2000-11-02
Abstract: This invention is directed to novel ammonolysis products including novel silazanes and polysilazanes characterized by repeating units of silicon-nitrogen in a polymeric compound having a reduced amount of Si-H bonds relative to the amount of Si-H bonds in the starting compound. Preparation of these novel ammonolysis products comprises introducing a starting compound containing at least one Si-H bond, such as a halosilane into a stoichiometric excess of anhydrous liquid ammonia wherein an ammonium halide is generated acting as an acid catalyst to provide an ionic and/or acidic environment for preparing the novel ammonolysis compounds. The prepared novel ammonolysis products are retained in a separate liquid-phase layer and distinct from the anhydrous liquid ammonia containing the ionized ammonium halide. Also provided are methods to purify ammonolysis products and to modify ammonolysis products by controllably increasing viscosity from a liquid to a solid and viscosities there between.
Patent PT-1299458-E (PT)
Title: Aqueous dispersion comprising viscous silicone oils crosslinkable by condensation into an adhering elastomer for use as sealants or paints and preparation method
Inventor: BOUVY BERNARD
IPC: C08J3/03
Filed: 2001-06-29
Abstract: The invention concerns an aqueous dispersion of viscous silicone oils capable of being crosslinked into an elastomer by water elimination (condensation). The invention aims at obtaining an aqueous silicone dispersion corresponding to an optimal compromise in terms of adherence of the crosslinked elastomer on all types of supports, and the colloidal stability of the dispersion during preparation and storage. Said aqueous dispersion comprises a viscous silicone oil A, optionally a crosslinking agent B, optionally an adhesion promoter C (silane), a filler D, a catalyst E, an emulsifier F, optionally a functional additive G and water. Said dispersion is characterised in that the filler D is input into the process for obtaining the dispersion, in the form of an aqueous suspension of at least a hydrophilic compound (CaCO3SiO2, TiO2, Al2/H2O, organic polymer latex). The invention also concerns the preparation of said particularly stable dispersion since it has a residual emulsion rate T not less than 70%. The invention is useful for producing concentrated sealants and elastomer coating for insulating polymer foam (polyurethane).
Patent PT-1347738-E (PT)
Title: Transparent oil-in-water emulsion cosmetic treatment composition
Inventor: RESTLE SERGE
IPC: A61K8/00
Filed: 2002-01-02
Abstract: A transparent composition for cosmetic treatment of keratinous materials comprising, in a cosmetically acceptable medium, at least a compound selected among polyols and mineral electrolytes, at least a volatile silicone, at least a siliconized surfactant, and at least a cationic surfactant in a concentration strictly higher than 0.5 wt. % relative to the composition total weight. The proportions of the polyols and mineral electrolytes are such that the (polyol and/or electrolyte)/oil ratio is not less than 2, the oil comprising at least the volatile silicone. A method for cosmetic treatment of keratinous materials using the transparent composition is also disclosed.
Patent PT-1499313-E (PT)
Title: Heterocyclic derivatives as opioid receptor modulators
Inventor: KAVASH ROBERT W
IPC: C07D217/26
Filed: 2003-04-17
Abstract: This invention is directed towards compounds of formula (II) as intermediates for opioid receptor modulators, antagonists, and agonists useful for the treatment of opioid modulated disorders such as pain and gastrointestinal disorders.
Patent PT-1501517-E (PT)
Title: Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
Inventor: BAIKER WOLFGANG
IPC: A61K45/06
Filed: 2003-04-17
Abstract: The present invention relates to a new pharmaceutical combination for treating benign prostatic hyperplasia (BPH) or for the long-term prevention of acute urinary retention (AUR).
Patent PT-1554094-E (PT)
Title: Chemically modified, natural cork and its use as a support in reactions on solid phase
Inventor: RODRIGUEZ EDUARD BARDAJI
IPC: B27K7/00
Filed: 2003-08-20
Abstract: The present invention relates to chemically modified, natural cork so that it contains reactive chemical groups anchored to its surface, preferably amine groups. It also discloses a process to produce the chemically modified, natural cork, as well as its use as a solid support to be applied to both chemical and biochemical processes on solid phase.
Patent PT-1785492-E (PT)
Title: Process for preparing docosahexaenoic acid and docosapentaenoic acid
Inventor: TANAKA SATOHIRO
IPC: A23L33/12
Filed: 1997-06-06
Abstract: There is provided a process for preparing lipids containing docosahexaenoic acid and/or docosapentaenoic acid, comprising: cultivating in a medium a microorganism of genus  Ulkenia  having the ability to produce lipids containing docosahexaenoic acid and/or docosapentaenoic acid, and recovering said lipids from a culture; wherein globose or oval cells and biflagellate zoospores are observed when the microorganism is cultured in a KMV liquid medium at 20°C in the dark, whereas a network of ectoplasm filaments is not observed.
Patent PT-1856159-E (PT)
Title: Chimeric recombinant antigens of toxoplasma gondii
Inventor: GARGANO NICOLA
IPC: C07K19/00
Filed: 2006-02-27
Abstract: The invention described herein relates to a method for combining antigen fragments of Toxoplasma gondii proteins, in the form of chimeric fusion products, and their use as diagnostic and immunogenic agents.
Patent PT-1963065-E (PT)
Title: Machine for optimized cutting of slabs in stone or lithoid material
Inventor: TONCELLI LUCA
IPC: B28D1/04
Filed: 2006-12-12
Abstract: A machine for optimized cutting of slabs (16) of stone or stone-like material lying on a primary bench (34) comprises a first beam (28) on which a plurality of spindles (30) are mounted and is movably supported on two travelways (24, 26). In turn each of the spindles (30), whose position is adjustable along the beam, support cutting disks (32) having a fixed axis of rotation parallel to the said first beam (28) which is parallel to the feeding direction (F) of the rough slabs (16) to be cut. A second beam (38) is mounted on the same travelways (24, 26), parallel to the first beam (28) and provided with a handling device comprising suction-cups (40, 42). Since the primary bench (34) is rotatable about a vertical axis, by varying in succession the direction of the rough slab (16) with respect to the first beam (28) it is possible to perform longitudinal cutting passes in order to obtain strips (46a-46f) as well as transverse cutting passes of one or more selected strips transferred by said handling device (40, 42) from the primary bench (34)to the auxiliary bench (44) in order to obtain tiles.
Patent PT-1966202-E (PT)
Title: Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
Inventor: RODGERS JAMES DAVID
IPC: A61K31/395
Filed: 2006-12-12
Abstract: The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines (I) and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
Patent PT-1911458-E (PT)
Title: Cell-permeable peptide inhibitors of the jnk signal transduction pathway
Inventor: BONNY CHRISTOPHE
IPC: A61K38/00
Filed: 2003-06-09
Abstract: The invention provides cell-permeable peptides that bind to JNK proteins and inhibit JNK-mediated effects in JNK-expressing cells.
Patent PT-1989293-E (PT)
Title: Prevascularized tissue transplant constructs for the reconstruction of a human or animal organ
Inventor: RAM-LIEBIG GOUYA
IPC: A61F2/04
Filed: 2007-02-28
Abstract: The invention relates to a tissue transplant construct for the reconstruction of a human or animal organ. Here said tissue transplant construct is intended to comprise (a) a biocompatible acellular membrane and (b) microvascular endothelial cells which penetrate the membrane, wherein microvascular structures of microvascular endothelial cells are formed within the membrane.
Patent PT-2049113-E (PT)
Title: Medicament for the enhancement of cognitive function and neuroprotection
Inventor: GIGLER GABOR
IPC: A61K31/501
Filed: 2007-07-03
Abstract: The invention relates the use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazole-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or pharmaceutically acceptable salts thereof for the preparation of medicaments suitable for the improvement of cognitive function or obtaining neuroprotective effect. The medicaments containing 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]isoxazol-3-yl)piperidin-1-yl]ethyl-amino}-2-methyl-3-(2H)pyridazinone of the Formula (I) or therapeutically acceptable salt thereof can be used for the treatment or prevention of neuronal death, mental decline, sclerosis multiplex, Creuzfeld-Jacobs disease, Huntington-syndrome, amyotrophic lateral sclerosis, Parkinson-disease, memory disturbance, loss of memory, amnesia, stroke or for the improvement of memory function or learning ability.
Patent PT-2231662-E (PT)
Title: 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
Inventor: PRICE STEPHEN
IPC: A61K31/437
Filed: 2008-12-18
Abstract: The invention relates to imidazopyridines of formula I with anti-cancer and/or anti-inflammatory activity and more specifically to imidazopyridines which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.(Formula I)
Patent PT-2455265-E (PT)
Title: Parking brake actuator
Inventor: CHANCELIER THIERRY
IPC: B60T7/04
Filed: 2011-11-04
Abstract: The actuator (100) has a case (110) for housing an electric motor driving via a worm gear formed of a nut controlling a screw (120). A plastic stiffener sleeve is fitted on an end of a rod (111) around a thrust bearing (130) and an endfitting (135) forming the stop of a sheath (142) of a brake cable i.e. bowden cable (140), for blocking the endfitting and the thrust bearing and avoiding deformation of an end of the brake cable beyond the thrust bearing, so as to align an inner cable (141) on an axis of the screw within the rod and prevent transverse force on the screw and the nut that entails. An independent claim is also included for a parking brake system controlled by a cable.
Patent PT-637436-E (PT)
Inventor: LUNDQUIST INGEMAR H
IPC: A61M25/00
Filed: 1994-05-12
Abstract: A medical probe device comprising a catheter having a stylet guide housing with at least one stylet port in a side thereof and stylet guide means for directing a flexible stylet outward through at least one stylet port and through intervening tissue to targeted tissues. The stylet guide housing has an optical viewing means positioned for viewing the stylet and adjacent structure which includes a fiber optic channel means for receiving a fiber optic viewing device. The fiber optic channel means can include a guide port means for directing longitudinal movement of a fiber optic device with respect to the stylet guide means in a viewing zone and a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across the end of a fiber optic device when positioned in the viewing zone. The optical viewing means can comprise a viewing window positioned in the stylet guide housing for viewing the stylet when it is directed outward from its respective stylet port. The optical viewing means can include a fiber optic channel in the stylet guide housing for receiving the a fiber optic viewing device and aligning the viewing end thereof with the viewing window. Windowed devices can include a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across a surface of the viewing window. <IMAGE>
Patent PT-690720-E (PT)
Inventor: LITTLE ROGER G II
IPC: A61P35/00
Filed: 1994-03-11
Abstract: The present invention provides therapeutic methods for treatment of conditions including the neutralization of the anti-coagulant activity of heparin, inhibition of angiogenesis, tumor and endothelial cell proliferation, and treatment of chronic inflammatory diseases by administration of bactericidal/permeability-increasing (BPI) protein products.
Patent PT-706385-E (PT)
Inventor: BALANDRIN MANUEL F
IPC: A61K31/16
Filed: 1994-06-10
Abstract: Isovaleramide has been found to exhibit mild anxiolytic activity at low to moderate dosage levels and mildly sedative at somewhat higher dosage levels. In contrast to certain other materials thought to be anxiolytic or mildly sedative, isovaleramide is non-cytotoxic and does not paradoxically stimulate the central nervous system. Isovaleramide is therefore useful as a mild anxiolytic and mild sedative which can be made available to the general public.
Patent PT-828704-E (PT)
Inventor: HUCKABEE BRIAN KEITH
IPC: C07C233/05
Filed: 1996-04-26
Abstract: The present invention provides a method of making (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid which comprises condensing isovaleraldehyde with an alkyl cyanoacetate to form a 2-cyano-5-methylhex-2-enoic acid alkyl ester; reacting the 2-cyano-5-methylhex-2-enoic acid alkyl ester with a dialkyl malonate to form 3-isobutylglutaric acid; forming the anhydride of 3-isobutylglutaric acid; reacting the anhydride with ammonia to form (+/-)-3-(carbamoylmethyl)-5-methylhexanoic acid; reacting (+/-)-3-(carbamoylmethyl)-5-methylhexanoic acid with (R)-(+)- alpha -phenylethylamine to obtain the (R)-(+)- alpha -phenylethylamine salt of (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid; combining the salt with an acid to obtain (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid; and reacting the (R)-(-)-3-carbamoylmethyl)-5-methylhexanoic acid with a Hofmann reagent to obtain (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid.
Patent PT-863760-E (PT)
Inventor: PETIT FRANCIS
IPC: A61K31/58
Filed: 1996-09-19
Abstract: A method of treating narcotic withdrawal symptoms in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of a compound having anti-mineralocorticoid activity sufficient to treat narcotic withdrawal sypmtoms.